These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 14204552)

  • 1. THE EFFECTS OF DEXTROTHYROXINE IN DIABETES.
    ZINN WJ; SCHLEISSNER LA
    Calif Med; 1964 Oct; 101(4):240-5. PubMed ID: 14204552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SODIUM DEXTROTHYROXINE THERAPY FOR HYPERCHOLESTEROLEMIA. THREE YEARS OF ADMINISTRATION TO CARDIOVASCULAR SUBJECTS.
    COHEN BM
    Geriatrics; 1964 Aug; 19():585-97. PubMed ID: 14201416
    [No Abstract]   [Full Text] [Related]  

  • 3. ORAL HYPOGLYCEMIC DRUGS: COMPARATIVE EVALUATION OF TOLBUTAMIDE, CHLORPROPAMIDE AND PHENFORMIN.
    MOSS JM; DELAWTER DE; GALLAGHER EJ
    Med Times; 1964 Jul; 92():645-54. PubMed ID: 14184191
    [No Abstract]   [Full Text] [Related]  

  • 4. The metabolic and clinical effects of pituitary adrenocorticotropic hormone (ACTH) in spontaneous hypoglycemosis.
    McQuarrie I; Bauer EG; Ziegler MR; Wright WS
    Bull Univ Minn Hosp Minn Med Found; 1949 Oct; 21(3):35-45. PubMed ID: 18128849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [ARTERIOSCLEROSIS AND HYPERCHOLESTEREMIA TREATED WITH DEXTROTHYROXIN].
    BASABE H; GENTILE FA; BLANDA H
    Sem Med; 1963 Jun; 122():1375-7. PubMed ID: 14073883
    [No Abstract]   [Full Text] [Related]  

  • 6. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug treatment of hypercholesterolemia. Experience with a combination of dextrothyroxine and betapyridylcarbinol (author's transel)].
    Schneider J; Schubotz R; Manteuffel Ev; Kaffarnik H
    Med Klin; 1978 Jun; 73(23):874-7. PubMed ID: 661731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [DRAMATIC INCIDENTS DURING THE TREATMENT WITH ORAL ANTIDIABETICS].
    ZSCHORNACK MR; JAROSS W
    Dtsch Z Verdau Stoffwechselkr; 1963 Dec; 23():240-50. PubMed ID: 14126119
    [No Abstract]   [Full Text] [Related]  

  • 9. COMPLICATIONS OF THERAPY WITH ORAL HYPOGLYCEMIC AGENTS.
    BALL JE; LUPIN AM; MARY CC; ELLIOT W
    J La State Med Soc; 1964 Oct; 116():353-6. PubMed ID: 14200369
    [No Abstract]   [Full Text] [Related]  

  • 10. Probable hypoglycemic adverse drug reaction associated with prickly pear cactus, glipizide, and metformin in a patient with type 2 diabetes mellitus.
    Sobieraj DM; Freyer CW
    Ann Pharmacother; 2010; 44(7-8):1334-7. PubMed ID: 20516361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [DAMAGE DUE TO ANTIDIABETIC TREATMENT].
    SAUER H
    Hippokrates; 1964 Sep; 35():720-7. PubMed ID: 14318059
    [No Abstract]   [Full Text] [Related]  

  • 12. [D-THYROXIN IN TREATMENT OF HYPERCHOLESTEROLEMIAS. APROPOS OF 42 OBSERVATIONS].
    WAREMBOURG H; JAILLARD J; LEBEURRE R
    Lille Med; 1964 Nov; 9():856-63. PubMed ID: 14233300
    [No Abstract]   [Full Text] [Related]  

  • 13. FURTHER STUDIES ON THE THERAPEUTIC VALUE OF SODIUM DEXTROTHYROXINE.
    STARR P
    Clin Pharmacol Ther; 1964; 5():728-36. PubMed ID: 14226190
    [No Abstract]   [Full Text] [Related]  

  • 14. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
    Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
    Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repaglinide plus single-dose insulin glargine: a safe regimen for low-risk type 2 diabetic patients who insist on fasting in Ramadan.
    Bakiner O; Ertorer ME; Bozkirli E; Tutuncu NB; Demirag NG
    Acta Diabetol; 2009 Mar; 46(1):63-5. PubMed ID: 18825302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
    Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
    Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One year of sodium dextrothyroxine therapy for hypercholesterolemia.
    COHEN BM
    Angiology; 1962 Feb; 13():69-74. PubMed ID: 13880229
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of combined recombinant insulin-like growth factor (IGF)-I and IGF binding protein-3 in type 2 diabetic patients on glycemic control and distribution of IGF-I and IGF-II among serum binding protein complexes.
    Clemmons DR; Sleevi M; Allan G; Sommer A
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2652-8. PubMed ID: 17426090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CLINICAL EFFECTS OF A NEW, POTENT, NON-TOXIC SULFONYLUREA (TOLAZAMIDE).
    GRINNELL EH; SKILLMAN TG; BARSE R; MOLLER CL
    Curr Ther Res Clin Exp; 1964 Jul; 6():433-41. PubMed ID: 14203273
    [No Abstract]   [Full Text] [Related]  

  • 20. THE SEPARATE HYPOLIPOPROTEINEMIC EFFECTS OF DEXTROTHYROXINE AND ETHYL CHLOROPHENOXYISOBUTYRATE.
    STRISOWER EH; STRISOWER B
    J Clin Endocrinol Metab; 1964 Feb; 24():139-44. PubMed ID: 14123837
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.